Dog Longevity Startup Loyal Secures $45 Million in Funding
Biotech startup Loyal has raised $45 million in equity to help bring its first longevity drug for dogs to market.
Biotech startup Loyal has raised $45 million in equity to help bring its first longevity drug for dogs to market.
